东宝生物：公司代血浆明胶（药典二部明胶）已经实现销售

Core Viewpoint - Dongbao Bio has confirmed that its artificial blood plasma gelatin has achieved sales, indicating progress in its product development and market entry [2] Company Summary - Dongbao Bio (300239.SZ) responded to an investor inquiry on October 24, stating that its artificial blood plasma gelatin (Pharmacopoeia gelatin) is now available for sale [2]